Patent Assignment
Reel/Frame 059631/0716
Assignment of Assignor's Interest
Recorded: 2022-04-19
Pages: 5
Assignee
ALNYLAM PHARMACEUTICALS, INC.
300 THIRD STREET, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties
(2)
Compositions and Methods for Silencing UGT1A1 Gene Expression
Compositions and Methods for Silencing UGT1A1 Gene Expression
Application:
62/910,866 →
Related Assignments
(1)
Other recorded transfers of the patents in this record — the chain of ownership.